Goring Hall Hospital, part of Circle Health Group, is proud to mark the 10-year anniversary of its Age-Related Macular Degeneration (AMD) service, celebrating a decade of dedicated care and innovative ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the development ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...

Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

The European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BAT2506 as a biosimilar to reference p ...

The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying ...

Maternal vitamin D status in early pregnancy is crucial for fetal growth and may reduce the risk of preterm birth, according ...

This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...

Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...